CBIO
Crescent Biopharma
CBIO
CBIO
31 hedge funds and large institutions have $77.4M invested in Crescent Biopharma in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less capital invested
Capital invested by funds: $109M → $77.4M (-$32M)
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$710K | |
| 2 | +$55.9K | |
| 3 | +$30.2K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$18.4K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$17.9K |
Top Sellers
| 1 | -$177K | |
| 2 | -$111K | |
| 3 | -$84K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$68.1K |
| 5 |
Renaissance Technologies
New York
|
-$64.5K |